Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial

A April A. N. Rose J Jennifer Maxwell E Emmanuelle Rousselle C Chantel L. Mukonoweshuro I Islam E. Elkholi M Melody Riaud M Marco Biondini E Erica Cianfarano I Isabel Soria-Bretones C Chantal Tobin (Princess Margaret Cancer Centre, University Health Network) M Meghan McGuire R Rhoda W. Y. Law A Andrew J. Elia (Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network) B Ben X. Wang (Princess Margaret Cancer Centre, University Health Network) I Ian King T Tong Zhang T Trevor J. Pugh (Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto) Z Zaid Saeed Kamil M Marcus Butler F Frances A. Shepherd N Natasha B. Leighl A Albiruni Abdul Razak A Aaron Hansen S Samuel D. Saibil (Princess Margaret Cancer Centre, University Health Network) P Philippe L. Bedard P Peter M. Siegel L Lillian L. Siu (Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto) D David W. Cescon (Princess Margaret Cancer Centre, University Health Network, Toronto) A Anna Spreafico